JAPAN-US-PHARMACEUTICAL-MERGER-OTSUKA-AVANIR

This picture taken on December 2, 2014 shows Japanese drug maker Otsuka Pharmaceutical president Tatsuo Higuchi announcing Otsuka will buy US drugmaker Avanir Pharmaceuticals for 3.54 billion USD in Tokyo. The Japanese pharmaceutical company is relatively small compared with some of its European rivals, but it has launched an aggressive expansion strategy in recent years with a slew of acquisitions to expand its drug portfolio and commercial capabilities. AFP PHOTO / JIJI PRESS JAPAN OUT (Photo credit should read JIJI PRESS/AFP via Getty Images)
This picture taken on December 2, 2014 shows Japanese drug maker Otsuka Pharmaceutical president Tatsuo Higuchi announcing Otsuka will buy US drugmaker Avanir Pharmaceuticals for 3.54 billion USD in Tokyo. The Japanese pharmaceutical company is relatively small compared with some of its European rivals, but it has launched an aggressive expansion strategy in recent years with a slew of acquisitions to expand its drug portfolio and commercial capabilities. AFP PHOTO / JIJI PRESS JAPAN OUT (Photo credit should read JIJI PRESS/AFP via Getty Images)
JAPAN-US-PHARMACEUTICAL-MERGER-OTSUKA-AVANIR
ACQUISTA UNA LICENZA
Come posso utilizzare questa immagine?
475,00 €
EUR

DETTAGLI

Restrizioni:
Contatta l'ufficio locale per informazioni su qualsiasi tipo di uso commerciale o promozionale. Diritti editoriali illimitati per Regno Unito, Stati Uniti, Irlanda, Italia, Spagna, Canada (escluso Quebec). Diritti editoriali limitati in altri Paesi. Contatta l'ufficio locale.JAPAN OUT
Attestazione:
JIJI PRESS / Stringer
N. Editorial:
459856504
Collezione:
AFP
Data di creazione:
2 dicembre 2014
Data di upload:
Tipo di licenza:
Rights-managed
Info sulla liberatoria:
Senza liberatoria. Ulteriori informazioni
Fonte:
AFP
Codice a barre:
JIJI PRESS
Nome oggetto:
Hkg10124989
Max. dimensione file:
2500 x 1615 px (21,17 x 13,67 cm) - 300 dpi - 983 KB